Has coronavirus disease 2019 changed clinical microbiology laboratories forever?

Papers of special note have been highlighted as: • of interest

References

• 1. Watson OJ, Barnsley G, Toor J, Hogan AB, Winskill P, Ghani AC. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect. Dis. 22(9), 1293–1302 (2022). • Impact of vaccinations.
  Medline CASGoogle Scholar
• 2. Holder, J. Tracking coronavirus vaccinations around the world. The New York Times, 13th March (2023). www.nytimes.com/interactive/2021/world/covid-vaccinations-tracker.html
  Google Scholar
• 3. American Society for Microbiology. How dangerous is the Delta variant (B.1.617.2)? (2021). https://asm.org/Articles/2021/July/How-Dangerous-is-the-Delta-Variant-B-1-617-2
  Google Scholar
• 4. Bálint G, Vörös-Horváth B, Széchenyi A. Omicron: increased transmissibility and decreased pathogenicity. Signal Transduct. Target Ther. 7(1), 151 (2022).
  MedlineGoogle Scholar
• 5. Chow EJ, Uyeki TM, Chu HY. The effects of the COVID-19 pandemic on community respiratory virus activity. Nat. Rev. Microbiol. 21(3), 195–210 (2023).
  Medline CASGoogle Scholar
• 6. Blondeau JM. Clinical microbiology laboratories and COVID-19: the calm before the storm. Future Microbiol. 15(15), 1419–1424 (2020).
  Google Scholar
• 7. Dokouhaki P, Blondeau JM. Advances in laboratory diagnostic technologies in clinical microbiology and what this means for clinical practice. Clin. Pract. 9(4), 347–352 (2012). • Complex factors for cocirculation of respiratory viruses.
  CASGoogle Scholar
• 8. Blondeau JM, Idelevich EA. The 24-h clinical microbiology service is essential for patient management. Future Microbiol. 13, 1625–1628 (2018).
  CASGoogle Scholar
• 9. Idelevich EA, Seifert H, Sundqvist M et al. Microbiological diagnostics of bloodstream infections in Europe–an ESGBIES survey. Clin. Microbiol. Infect. 25(11), 1399–1407 (2019).
  Medline CASGoogle Scholar
• 10. Colzani E. Beyond morbidity and mortality: the burden of infectious diseases on healthcare services. Epidemiol. Infect. 147, e251 (2019).
  Google Scholar
• 11. Hamis AA, Md Bukhori AB, Heng PP et al. Strategies, challenges and opportunities in the implementation of COVID-19 field hospitals: a scoping review. BMJ Open 13(3), e067227 (2023).
  MedlineGoogle Scholar
• 12. Morgan DJ, Malani P, Diekema DJ. Diagnostic stewardship-leveraging the laboratory to improve antimicrobial use. JAMA 318(7), 607–608 (2017).
  MedlineGoogle Scholar
• 13. Liu VX, Fielding-Singh V, Greene JD et al. The timing of early antibiotics and hospital mortality in sepsis. Am. J. Respir. Crit. Care Med. 196(7), 856–863 (2017).
  MedlineGoogle Scholar
• 14. Im Y, Kang D, Ko RE et al. Time-to-antibiotics and clinical outcomes in patients with sepsis and septic shock: a prospective nationwide multicenter cohort study. Crit. Care 26(1), 19 (2022). • Importance of diagnostic stewardship.
  MedlineGoogle Scholar
• 15. Wang Y, Zhao D, Liu X, Chen X, Xiao W, Feng L. Early administration of Paxlovid reduces the viral elimination time in patients infected with SARS-CoV-2 Omicron variants. J. Med. Virol. 95(1), e28443 (2023). • Impact of early antibiotic treatment.
  Medline CASGoogle Scholar
• 16. Khunte M, Kumar S, Salomon JA, Bilinski A. Projected COVID-19 mortality reduction from Paxlovid rollout. JAMA Health Forum 4(3), e230046 (2023).
  MedlineGoogle Scholar
• 17. Singh AK, Singh A, Singh R, Misra A. An updated practical guideline on use of molnupiravir and comparison with agents having emergency use authorization for treatment of COVID-19. Diabetes Metab. Syndr. 16(2), doi: 10.1016/j.dsx.2022.102396 (2022). • The value of Paxlovid with early administration.
  Google Scholar
• 18. Poole S, Townsend J, Wertheim H et al. How are rapid diagnostic tests for infectious diseases used in clinical practice: a global survey by the International Society of Antimicrobial Chemotherapy (ISAC). Eur. J. Clin. Microbiol. Infect. Dis. 40(2), 429–434 (2021).
  MedlineGoogle Scholar
• 19. Idelevich EA, Becker K. How to accelerate antimicrobial susceptibility testing. Clin. Microbiol. Infect. 25(11), 1347–1355 (2019).
  Medline CASGoogle Scholar
• 20. WHO. Antimicrobial resistance (2021). www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance • A snapshot of how rapid diagnostic tests are used in various countries.
  Google Scholar